The effect of cilostazol on vasospasm after subarachnoid hemorrhage: a role for spreading depolarizatio
Not Applicable
- Conditions
- subarachnoid hemorrhage
- Registration Number
- JPRN-UMIN000008225
- Lead Sponsor
- Yamaguchi University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
The patients treated with surgical clipping or coil embolizaion after 72 hours of the onset of subarachnoid henorrhage.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of cerebral vasospasm in the cilostazol treated group.
- Secondary Outcome Measures
Name Time Method Clinical outcome (The Modified Rankin Scale; mRS) 30 days and 90 days after the onset of the patients treated with cilostazol. Incidence of cerebral vasospasm detected on angiography. Cerebral microcirculation of patients treated with cilostazol.